ZUH:CA:TSX-BMO Equal Weight US Health Care (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 70.72

Change

+0.62 (+0.88)%

Market Cap

CAD 0.26B

Volume

1.06K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-05 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.43 (+1.03%)

CAD 3.04B
ZWU:CA BMO Covered Call Utilities ETF

+0.08 (+0.74%)

CAD 1.92B
XIT:CA iShares S&P/TSX Capped Informa..

+0.55 (+0.94%)

CAD 0.66B
TXF:CA First Asset Tech Giants Covere..

+0.23 (+1.08%)

CAD 0.65B
HTA:CA Harvest Tech Achievers Growth ..

+0.18 (+0.97%)

CAD 0.64B
XHC:CA iShares Global Healthcare (CAD..

+0.07 (+0.10%)

CAD 0.63B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.42 (+1.92%)

CAD 0.55B
CWW:CA iShares Global Water Common Cl..

+0.87 (+1.50%)

CAD 0.33B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.46 (+1.66%)

CAD 0.33B
COW:CA iShares Global Agriculture Com..

+0.63 (+0.97%)

CAD 0.28B

ETFs Containing ZUH:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.72% 17% F 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.72% 17% F 29% F
Trailing 12 Months  
Capital Gain 13.95% 34% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.95% 34% F 43% F
Trailing 5 Years  
Capital Gain 27.29% 37% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.29% 37% F 58% F
Average Annual (5 Year Horizon)  
Capital Gain 4.54% 31% F 51% F
Dividend Return 4.92% 26% F 49% F
Total Return 0.38% 28% F 27% F
Risk Return Profile  
Volatility (Standard Deviation) 16.33% 63% D 52% F
Risk Adjusted Return 30.11% 29% F 48% F
Market Capitalization 0.26B 71% C- 50% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.